Thromboembolic disease markers

Inventors: Eduardo Salas (Barcelona, ES); José Manuel Soria (Barcelona, ES); Miroslava Ogorelkova (Barcelona, ES); Roberto Elosua (Barcelona, ES); Joan S. Vila (Barcelona, ES); Sergio Castillo (Barcelona, ES)

Assignee: Gendiag.exe, S.L.

C12Q1/6883 C12Q1/6827 C12Q1/6837 C12Q2600/106 C12Q2600/112 C12Q2600/118 C12Q2600/156

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 10,023,914
App. No.: 14/886,463
Granted: Jul 17, 2018
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The invention relates to a method for a more appropriate thromboembolic event risk assessment based on the presence of different genetic variant. The invention also relates to a method for determining the risk of suffering a thromboembolism disease by combining the absence or presence of one or more polymorphic markers in a sample from the subject with conventional risk factors for thromboembolism as well as computer-implemented means for carrying out said method.

Claims (2)

1. A kit comprising primer pairs consisting of SEQ ID NOs: 1-24 wherein each primer is labeled with a detectable dye.

2. The kit of claim 1 , wherein the dye is SYBR Green I, YO-PRO-I, thiazole orange, Hex, pico green edans, FAM, or TET.

Assignments (4)

CHANGE OF NAME Recorded Nov 10, 2021

From: GENINCODE UK, LTD.

To: GENINCODE LIMITED

Reel/Frame 058067/0612 →

CHANGE OF NAME Recorded Nov 10, 2021

From: GENINCODE LIMITED

To: GENINCODE PLC

Reel/Frame 058086/0302 →